Among women with a patent reproductive tract, risk for ovarian cancer was slightly elevated in association with use of powder in the genital area.
Studies examining whether genital powder — which often contains talc — causes ovarian cancer have been inconsistent and potentially subject to bias. Now, investigators have pooled data from four cohort studies including >250,000 women, of whom 39% reported genital powder use and 10% reported long-term use.
During a median 11 years' follow-up, 2168 participants developed ovarian cancer. Overall, risk for ovarian cancer was not statistically significantly increased in users (relative risk, 1.09; 95% confidence interval, 0.99–1.17); however, among women with a patent reproductive tract, risk was slightly higher (RR, 1.13; 95% CI, 1.01–1.26).
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)